Photo of Bexis

A couple of weeks ago, we linked to Part One of Anthony Sebok and Benjamin Zipursky’s Findlaw article about Wyeth v. Levine, the drug preemption case pending in the U.S. Supreme Court.

Sebok and Zipursky have now published Part Two of that article.

Although we disagree with the conclusion that the authors reach, here’s a link to Part Two.

(We’re publishing this post solely as a public service to our readers. We alerted you to Part One of the article; we’re alerting you to Part Two. Please don’t take our creation of this link as an endorsement of Sebok and Zipursky’s conclusions.)

Drug & Device Resources

Bexis’ Book

FDA-regulated products now account for an estimated one-fifth of overall economic activity in the U.S. They have also been the focus of a litigation explosion. This timely guide covers all aspects of litigation involving drugs, medical devices, vaccines and other FDA-regulated prescription products.
Learn More About This Book